Janux Therapeutics Inc (JANX)

R&D Expense Growth

15.59%

Quarterly · Period ending:

JANX logo

JANX R&D Expense Growth

Latest reported15.59%
JANX Quarterly R&D Growth (QoQ) (0.00% → 15.59%)
High-resolution chart · PNG

JANX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
15.5932%
-15.0089%
-8.8972%
-0.101%
38.3516%
20.422%
11.7761%
24.9429%
5.8849%
14.9416%
2.9347%
-20.3163%
-5.9313%
2.7925%
12.3535%
-2.4776%
38.315%
-8.8191%
32.8694%
77.4541%
146.0779%
95.4315%
18.1055%
23.9227%
22.5865%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.